NCT03804424 2024-11-12
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated
Clinical Trials
6 trialsNCT03272633 2023-06-26
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Terminated
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT03173430 2020-02-07
Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT00470093 2018-11-16
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT01537861 2015-01-26
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated